Cita APA

Schuler, M., Nam, D., Lim, D. W., Azaro Pedrazzoli, A. B., Bauer, T., Bang, Y., & Su, W. (2020). Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts.

Citación estilo Chicago

Schuler, Martin, Do-Hyun Nam, Darren Wan-Teck Lim, Analía Beatriz Azaro Pedrazzoli, Todd Bauer, Yung-Jue Bang, y Wu-Chou Su. Phase 1 Study of Capmatinib in MET-positive Solid Tumor Patients: Dose Escalation and Expansion of Selected Cohorts. 2020.

Cita MLA

Schuler, Martin, et al. Phase 1 Study of Capmatinib in MET-positive Solid Tumor Patients: Dose Escalation and Expansion of Selected Cohorts. 2020.